Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09VRZ
|
||||
| Former ID |
DIB012549
|
||||
| Drug Name |
AZM-131
|
||||
| Indication | Obesity [ICD9: 278; ICD10:E66] | Terminated | [1] | ||
| Company |
Alizyme plc
|
||||
| Target and Pathway | |||||
| Target(s) | Triacylglycerol lipase, pancreatic | Target Info | Modulator | [2] | |
| BioCyc Pathway | Triacylglycerol degradation | ||||
| Retinol biosynthesis | |||||
| KEGG Pathway | Glycerolipid metabolism | ||||
| Metabolic pathways | |||||
| Pancreatic secretion | |||||
| Fat digestion and absorption | |||||
| Vitamin digestion and absorption | |||||
| Reactome | Retinoid metabolism and transport | ||||
| WikiPathways | Visual phototransduction | ||||
| Lipid digestion, mobilization, and transport | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008694) | ||||
| REF 2 | US patent application no. 7217,697, Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.